ÀÇÇб³À°ÀÇ ÀÌÇØ
- ÀúÀÚ(±Û)À±¼º»ó ¿Ü
- ÃâÆÇ»ç°æÈñ´ëÇб³ÃâÆÇ¹®È¿ø
- ¹ßÇàÀÏ2013³â 06¿ù 30ÀÏ
µÎÅë Ä¡·áÀÇ ¸íÀÇ, Á¤È®ÇÑ Áø´ÜÀÇ ´ÞÀÎ
³úÁ¹Áß, µÎÅë, ¸»ÃʽŰ溴 ºÐ¾ßÀÇ Àü¹®°¡·Î ÀÎÁ¤¹Þ´Â À±¼º»ó ±³¼ö´Â Á¤È®ÇÑ Áø´Ü°ú ȯÀÚ Áß½ÉÀÇ ¸ÂÃãÇü Ä¡·á·Î ¶Ù¾î³ ÀÓ»ó ¼º°ú¸¦ º¸À̰í ÀÖ´Ù. ÃֽŠ½Å°æ¿µ»ó ±â¼úÀ» Ȱ¿ëÇÑ Çõ½ÅÀûÀÎ Áø´Ü ¹æ¹ý °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, ´ÙÇÐÁ¦Àû Á¢±ÙÀ» ÅëÇØ º¹ÇÕÀûÀÎ ½Å°æ°è Áúȯ Ä¡·á¿¡ ±â¿©Çϰí ÀÖ´Ù. ±¹³»¿Ü Çмú Ȱµ¿À» ÅëÇØ ½Å°æ°úÇÐ ¹ßÀüÀ» ¼±µµÇϰí ÀÖÀ¸¸ç, ƯÈ÷ µÎÅë Ä¡·á¿¡ ´ëÇÑ ¿¬±¸·Î ÁÖ¸ñ¹Þ°í ÀÖ´Ù.
| Á¦ ¸ñ | The Little ICU Book of Facts and Formulas | ||
|---|---|---|---|
| ÃâÆÇ»ç | ¹ßÇàÀÏ | 2012³â 06¿ù | |
| Á¦ ¸ñ | ³úÁ¹ÁßÀÇ visual text | ||
|---|---|---|---|
| ÃâÆÇ»ç | ¹ßÇàÀÏ | 2011³â 05¿ù | |
| Á¦ ¸ñ | Serum level of IL-1¥â in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD) | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2020 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | Bone health in neuromyelitis optica: Bone mineral density and fractures | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2020 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | Interactive Effects of Apolipoprotein E epsilon 4 and Triiodothyronine on Memory Performance in Patients With Subjective Cognitive Decline | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2020 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | Spontaneous interhemispheric subdural hematoma presenting as epilepsia partialis continua | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2020 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | ´ÜÀÏ ±â°ü¿¡¼ °æÇèÇÑ ºñ±â¾ï»ó½ÇÇü °æµµ ÀÎÁöÀå¾ÖÀÇ ÀÓ»óÀû °íÂû | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2019 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | Isolated Choroid Plexus Infarction Presenting as Psychomotor Slowing | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2019 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | ±ÃµÕ½Å°æÀÇ ½Å°æ¼º Á¾¾çÀ¸·Î ÀÎÇÑ ÇÏÁöºÒ¾ÈÁõÈıº 1¿¹ | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2017 | ¹ßÇ¥Áö | |

°æÈñ´ëÇб³º´¿øÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇϸç, ±¹³» ÀÇ·á°è¸¦ ¼±µµÇÏ´Â »ó±ÞÁ¾ÇÕº´¿øÀÔ´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú°ú Àåºñ¸¦ Ȱ¿ëÇÏ¿© ȯÀڵ鿡°Ô ÃÖ»óÀÇ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÁßÁõÁúȯ Ä¡·á ¹× ¿¬±¸¿¡ °Á¡À» º¸À̸ç, ´ÙÇÐÁ¦ ÇùÁø ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚÀÇ °Ç°À» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. °æÈñ´ëÇб³º´¿øÀº ȯÀÚµéÀÇ ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϸç, Áö¼ÓÀûÀ¸·Î ÀÇ·á ǰÁú Çâ»ó°ú ¿¬±¸ °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù.
¼¿ïƯº°½Ã µ¿´ë¹®±¸ °æÈñ´ë·Î 23 °æÈñ´ëÇб³º´¿ø